国产精品又长又粗又爽又黄的毛片, 国产AV无码专区亚洲AV毛片搜, 丰满人妻被猛烈进入中文字幕四川, 国产精品一区二区三区国产女人喷,亚洲国产欧美日韩图片在线人,潘娇娇337p人艺体艺术,成人免费无码大片a毛片古装,一本到高清视频免费,人妻在线视频免费看

更新于 今天

分子信息學(xué)高級(jí)經(jīng)理(MJ013367)

4-6萬(wàn)·14薪
  • 上海閔行區(qū)
  • 5-10年
  • 博士
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 工作環(huán)境好
  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 氛圍活躍
  • 人際關(guān)系好
  • 交通便利
  • 非常鍛煉人
  • 能學(xué)到東西

職位描述

免疫組學(xué)基因組學(xué)
We have an open position in the Department of Molecular Informatics at Shanghai Hengrui
Pharmaceutical Co., Ltd. This newly created role will lead a team tasked with
exploring, developing, and implementing research informatics, data science, and
artificial intelligence technologies to maintain and optimize the R&D
informatics systems, enhance the development of the AIDD platform, and expedite
the discovery of small molecule and biologics drugs. Furthermore, the
successful candidate will play an integral role in advancing key technologies
and sharing computational expertise within the organization.

Requirements:

1. PhD degree in chemistry, pharmacy, life sciences, or computational sciences, and
a proven track record in research informatics, CADD, or AIDD.
2. At least 5 years of experience in the pharmaceutical industry, with experience in
AI-powered biotech or drug discovery companies preferred.
3. Extensive experience in managing informatics systems and/or developing databases.
4. Expertise in machine learning (ML) and deep learning (DL), with experience in developing
or applying ML/DL methods in at least one of the following fields: molecular
property prediction, molecular generation, retrosynthesis prediction, protein
design, biomedical text mining, or bioinformatics analysis, etc.
5. Skilled in scientific programming, with proficiency in Python or R highly preferred.
6. The ability to work effectively within a multi-discipline environment is essential.
7. Good verbal and written communication skills, and fluent in Chinese and English.
8. Fast learner, team player, creative thinker and passionate about drug discovery and
life sciences.

工作地點(diǎn)

閔行區(qū)上海恒瑞醫(yī)藥有限公司

職位發(fā)布者

邱菲/HRBP

今日活躍
立即溝通
公司Logo江蘇恒瑞醫(yī)藥股份有限公司公司標(biāo)簽
恒瑞醫(yī)藥(股票代碼:600276.SH,01276.HK)創(chuàng)立于1970年,是一家專注研發(fā)、生產(chǎn)及推廣高品質(zhì)藥物的創(chuàng)新型國(guó)際化制藥企業(yè),聚焦腫瘤、代謝和心血管疾病、免疫和呼吸系統(tǒng)疾病以及神經(jīng)科學(xué)等領(lǐng)域進(jìn)行新藥研發(fā),是國(guó)內(nèi)最具創(chuàng)新能力的制藥龍頭企業(yè)之一。五十余年來(lái),恒瑞醫(yī)藥始終堅(jiān)持為患者服務(wù)的初心,努力守護(hù)患者健康生活和生命質(zhì)量,攻堅(jiān)克難推進(jìn)醫(yī)藥產(chǎn)業(yè)高質(zhì)量發(fā)展。在美國(guó)制藥經(jīng)理人雜志公布的全球制藥企業(yè)TOP50榜單中,恒瑞醫(yī)藥已連續(xù)6年上榜;國(guó)際知名咨詢機(jī)構(gòu)Citeline發(fā)布的全球TOP25管線規(guī)模制藥公司榜單,恒瑞醫(yī)藥連續(xù)4年上榜,2025年自研管線數(shù)量位居全球第二;中國(guó)醫(yī)藥工業(yè)信息中心歷年發(fā)布的“中國(guó)醫(yī)藥研發(fā)產(chǎn)品線最佳工業(yè)企業(yè)”,恒瑞醫(yī)藥已12次登頂榜首。
公司主頁(yè)